insulin
insulin is a pharmaceutical drug with 262 clinical trials. Currently 21 active trials ongoing. Historical success rate of 93.0%.
Success Metrics
Based on 172 completed trials
Phase Distribution
Phase Distribution
41
Early Stage
43
Mid Stage
96
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
85.6%
172 of 201 finished
14.4%
29 ended early
21
trials recruiting
262
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Antidiabetic Medications and Risk of Cancer
FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)
Effect of Short-Term Beta-Cell Rest in Adolescents and Young Adults With Type 2 Diabetes Mellitus
Triple Therapy in T1DM
A Study of GS3-007a for Oral Suspension in the Diagnosis of Adult Growth Hormone Deficiency (AGHD)
Clinical Trials (262)
Antidiabetic Medications and Risk of Cancer
FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)
Effect of Short-Term Beta-Cell Rest in Adolescents and Young Adults With Type 2 Diabetes Mellitus
Triple Therapy in T1DM
A Study of GS3-007a for Oral Suspension in the Diagnosis of Adult Growth Hormone Deficiency (AGHD)
Daily Glycaemic Variability in Frail or Disabled Older Patients With Diabetes Over 75 Treated With Basal Insulin
Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance
Effects of Cofrogliptin on Beta-Cell Function in LADA Patients
Intensive Versus Conventional Hyperglycemic Control in Hospitalized Non-critically Ill Patients
Permissive Versus Strict Intrapartum Glucose Management in Type 1 Diabetes (PRISM-T1D)
Open-Label Study of Dimethyl Fumarate in Adults With Type 1 Diabetes
Regional Lipolysis Insulin Regulation
Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of Glucotoxicity
Gestational Diabetes and Pharmacotherapy (GAP)
A Prospective, Multicenter, Randomized, Open-label Study of 12 Week Duration to Evaluate the Effect of VILDagliptin Added to Insulin on Glycaemic Control in haemoDIALyzed Patients With Type 2 Diabetes: Probe Analysis of CGM
Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes
Prevention of Mild-to-moderate Hypoglycemia in Type 1 Diabetes
Glycemic Variations During the Menstrual Cycle in Women With Type 1 Diabetes
Clinical Trial To Determine The Effectiveness And Safety Of Topical Insulin In Dry Eye
Reprometabolic Syndrome Mediates Subfertility in Obesity
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 262